134 related articles for article (PubMed ID: 35364257)
1. Inhibitory effect of aptamer-carbon dot nanomaterial-siRNA complex on the metastasis of hepatocellular carcinoma cells by interfering with FMRP.
Zhao X; Yang J; Zhang J; Wang X; Chen L; Zhang C; Shen Z
Eur J Pharm Biopharm; 2022 May; 174():47-55. PubMed ID: 35364257
[TBL] [Abstract][Full Text] [Related]
2. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
[TBL] [Abstract][Full Text] [Related]
3. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
5. Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D models.
Xu J; Gu M; Hooi L; Toh TB; Thng DKH; Lim JJ; Chow EK
Nanoscale; 2021 Oct; 13(38):16131-16145. PubMed ID: 34542130
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA-mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma.
Hajiasgharzadeh K; Somi MH; Shanehbandi D; Mokhtarzadeh A; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3263-3276. PubMed ID: 30362510
[TBL] [Abstract][Full Text] [Related]
7. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
[TBL] [Abstract][Full Text] [Related]
8. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
Huang XH; Jian WH; Wu ZF; Zhao J; Wang H; Li W; Xia JT
Oncotarget; 2014 Jul; 5(14):5570-80. PubMed ID: 25015194
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
11. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L; Perrone F; Garziera M; Farra R; Grassi M; Musiani F; Russo Spena C; Salis B; De Stefano L; Toffoli G; Rizzolio F; Tonon F; Abrami M; Chiarappa G; Pozzato G; Forte G; Grassi G; Dapas B
Expert Opin Drug Deliv; 2017 Jun; 14(6):797-810. PubMed ID: 28266887
[TBL] [Abstract][Full Text] [Related]
12. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
13. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo.
Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM
Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758
[TBL] [Abstract][Full Text] [Related]
14. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
[TBL] [Abstract][Full Text] [Related]
15. The Role of Small Interfering RNAs in Hepatocellular Carcinoma.
Chen F; Zhang W; Gao X; Yuan H; Liu K
J Gastrointest Cancer; 2024 Mar; 55(1):26-40. PubMed ID: 37432548
[TBL] [Abstract][Full Text] [Related]
16. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
17. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.
Li H; Fu X; Chen Y; Hong Y; Tan Y; Cao H; Wu M; Wang H
Gastroenterology; 2005 Jun; 128(7):2029-41. PubMed ID: 15940635
[TBL] [Abstract][Full Text] [Related]
18. DNA Methyltransferase 1: A Potential Gene Therapy Target for Hepatocellular Carcinoma?
Jiang C; Gong F
Oncol Res Treat; 2016; 39(7-8):448-52. PubMed ID: 27487275
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.
Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.
Hu YJ; Li HY; Qiu KJ; Li DC; Zhou JH; Hu YH; Zhang FM
Int J Mol Med; 2014 Oct; 34(4):1081-6. PubMed ID: 25110169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
